United States · FDA National Drug Code directory
tadalafil
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-857_38689a7c-8af1-e4b0-e063-6394a90a94d8
- Product NDC
- 76420-857
- Form
- TABLET, FILM COATED
- Composition / generic term
- tadalafil
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190326
- Source listing expiry
- 20261231
Source-listed ingredients
- TADALAFIL — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (76420-857-01) · 76420-857-01
- 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (76420-857-05) · 76420-857-05
- 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (76420-857-30) · 76420-857-30
- 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (76420-857-60) · 76420-857-60
- 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (76420-857-90) · 76420-857-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →